BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 22167296)

  • 1. Walking a tightrope: oncologists' perspective on providing information to women with recurrent ovarian cancer (ROC) during the medical encounter.
    Elit L; Charles C; Gafni A; Ranford J; Gold ST; Gold I
    Support Care Cancer; 2012 Oct; 20(10):2327-33. PubMed ID: 22167296
    [TBL] [Abstract][Full Text] [Related]  

  • 2. How oncologists communicate information to women with recurrent ovarian cancer in the context of treatment decision making in the medical encounter.
    Elit LM; Charles C; Gafni A; Ranford J; Tedford-Gold S; Gold I
    Health Expect; 2015 Oct; 18(5):1066-80. PubMed ID: 23663240
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Oncologists' Perceptions of Recurrent Ovarian Cancer Patients' Preference for Participation in Treatment Decision Making and Strategies for When and How to Involve Patients in This Process.
    Elit L; Charles CA; Gafni A
    Int J Gynecol Cancer; 2015 Nov; 25(9):1717-23. PubMed ID: 26501437
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effect of priority setting decisions for new cancer drugs on medical oncologists' practice in Ontario: a qualitative study.
    Berry SR; Hubay S; Soibelman H; Martin DK
    BMC Health Serv Res; 2007 Nov; 7():193. PubMed ID: 18042302
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Experience of Being Aware of Disease Status in Women with Recurrent Ovarian Cancer: A Phenomenological Study.
    Finlayson CS; Fu MR; Squires A; Applebaum A; Van Cleave J; O'Cearbhaill R; DeRosa AP
    J Palliat Med; 2019 Apr; 22(4):377-384. PubMed ID: 30407108
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The choice is yours? How women with ovarian cancer make sense of treatment choices.
    Ziebland S; Evans J; McPherson A
    Patient Educ Couns; 2006 Sep; 62(3):361-7. PubMed ID: 16876377
    [TBL] [Abstract][Full Text] [Related]  

  • 7. It's a choice to move forward: women's perceptions about treatment decision making in recurrent ovarian cancer.
    Elit L; Charles C; Dimitry S; Tedford-Gold S; Gafni A; Gold I; Whelan T
    Psychooncology; 2010 Mar; 19(3):318-25. PubMed ID: 19319830
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment recommendations within the leeway of clinical guidelines: A qualitative interview study on oncologists' clinical deliberation.
    Otte I; Salloch S; Reinacher-Schick A; Vollmann J
    BMC Cancer; 2017 Nov; 17(1):780. PubMed ID: 29162047
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 'Hitting you over the head': oncologists' disclosure of prognosis to advanced cancer patients.
    Gordon EJ; Daugherty CK
    Bioethics; 2003 Apr; 17(2):142-68. PubMed ID: 12812182
    [TBL] [Abstract][Full Text] [Related]  

  • 10. What patients value when oncologists give news of cancer recurrence: commentary on specific moments in audio-recorded conversations.
    Back AL; Trinidad SB; Hopley EK; Arnold RM; Baile WF; Edwards KA
    Oncologist; 2011; 16(3):342-50. PubMed ID: 21349951
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A preliminary survey of oncologists' perceptions of quality of life information.
    Bezjak A; Ng P; Taylor K; MacDonald K; Depetrillo AD
    Psychooncology; 1997 Jun; 6(2):107-13. PubMed ID: 9205968
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Patients' and oncologists' views on how oncologists may best address patients' emotions during consultations: An interview study.
    Visser LNC; Schepers S; Tollenaar MS; de Haes HCJM; Smets EMA
    Patient Educ Couns; 2018 Jul; 101(7):1223-1231. PubMed ID: 29534845
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Generalists and oncologists show similar care practices and outcomes for hospitalized late-stage cancer patients. SUPPORT Investigators. Study to Understand Prognoses and Preferences for Outcomes and Risks for Treatment.
    Rose JH; O'Toole EE; Dawson NV; Thomas C; Connors AF; Wenger N; Phillips RS; Hamel MB; Reding DT; Cohen HJ; Lynn J
    Med Care; 2000 Nov; 38(11):1103-18. PubMed ID: 11078051
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Conveying genomic recurrence risk estimates to patients with early-stage breast cancer: oncologist perspectives.
    Spellman E; Sulayman N; Eggly S; Peshkin BN; Isaacs C; Schwartz MD; O'Neill SC
    Psychooncology; 2013 Sep; 22(9):2110-6. PubMed ID: 23447452
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Difficult patient loss and physician culture for oncologists grieving patient loss.
    Granek L; Krzyzanowska MK; Tozer R; Mazzotta P
    J Palliat Med; 2012 Nov; 15(11):1254-60. PubMed ID: 23016965
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pediatric oncologists' coping strategies for dealing with patient death.
    Granek L; Barrera M; Scheinemann K; Bartels U
    J Psychosoc Oncol; 2016; 34(1-2):39-59. PubMed ID: 26865337
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Exploration of oncologists' attitudes toward and perceived value of patient-reported outcomes.
    Meldahl ML; Acaster S; Hayes RP
    Qual Life Res; 2013 May; 22(4):725-31. PubMed ID: 22684493
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Decision making in pediatric oncology: Views of parents and physicians in two European countries.
    Badarau DO; Ruhe K; Kühne T; De Clercq E; Colita A; Elger BS; Wangmo T
    AJOB Empir Bioeth; 2017; 8(1):21-31. PubMed ID: 28949870
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Women's experiences with recurrent ovarian cancer.
    Howell D; Fitch MI; Deane KA
    Cancer Nurs; 2003 Feb; 26(1):10-7. PubMed ID: 12556708
    [TBL] [Abstract][Full Text] [Related]  

  • 20. What makes decision-making difficult for oncologists faced with critical situations? The socio-affective side of the physician-patient relationship.
    Restivo L; Julian-Reynier C; Peyla L; Apostolidis T
    J Health Psychol; 2020 Sep; 25(10-11):1396-1409. PubMed ID: 29417840
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.